Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × ofatumumab × Lymphoid × Clear all

Phase

Status

Sponsor Class

OTHER 44 INDUSTRY 26 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 76 Vincristine 69 Doxorubicin 56 Prednisone 54 Cytarabine 49 Methotrexate 48 Rituximab 40 Etoposide 38 Radiotherapy 36 Filgrastim 34 Dexamethasone 34 Granulocyte Colony-Stimulating Factor 23 Mercaptopurine 22 Leucovorin 21 Daunorubicin 18 Calcium Dobesilate 18 pegaspargase 16 Asparaginase 15 merphos 14 Peripheral Blood Stem Cell Transplantation 14 Bleomycin 14 Thioguanine 13 Specimen Handling 13 Hydrocortisone 11 Gene Expression Profiling 11 fludarabine phosphate 10 Vinblastine 10 Methylprednisolone 10 Ifosfamide 10 Gemcitabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01481272 2021-12-27

PLRG8

Polish Lymphoma Research Group

Phase 2 Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡